Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)

PHASE3TerminatedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

December 22, 2021

Study Completion Date

December 22, 2021

Conditions
Ovarian Cancer
Interventions
DRUG

Chemotherapy + avelumab followed by avelumab + talazoparib

"Chemotherapy Period Paclitaxel Carboplatin Avelumab~Maintenance Period Avelumab Talazoparib"

DRUG

Chemotherapy followed by talazoparib maintenance

"Chemotherapy Period Paclitaxel Carboplatin~Maintenance Period Talazoparib"

DRUG

Chemotherapy + bevacizumab followed by bevacizumab

"Chemotherapy Period Paclitaxel Carboplatin Bevacizumab~Maintenance Period Bevacizumab"

Trial Locations (72)

112

Department of Radiology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei

Division of Pharmacy, Koo Foundation Sun Yat-Sen Cancer Center, Taipei

Koo Foundation Sun Yat-Sen Cancer Center, Taipei

3002

Epworth Foundation trading as Epworth HealthCare, East Melbourne

3121

Epworth HealthCare, Clinical Trials & Research Centre, Richmond

5000

CHU-UCL Namur/Site Sainte Elisabeth, Namur

10461

Montefiore Medical Center - EPC, The Bronx

Montefiore Medical Center, Department of Obstetrics and Gynecology and Women's Health, The Bronx

Montefiore Medical Center, The Bronx

10467

Montefiore Medical Center-Centennial Facility, The Bronx

11217

Taipei Veterans General Hospital, Taipei

11501

NYU Winthrop Hospital, Gynecologic Oncology, Mineola

NYU Winthrop Hospital, Infusion Center, Mineola

NYU Winthrop Radiology, Mineola

20141

Istituto Europeo di Oncologia (IEO), Milan

23320

Virginia Oncology Associates, Chesapeake

23456

Virginia Oncology Associates, Virginia Beach

23502

Virginia Oncology Associates, Norfolk

37055

Tennessee Oncology, PLLC, Dickson

37066

Tennessee Oncology, PLLC, Gallatin

37067

Tennessee Oncology, PLLC, Franklin

37076

Tennessee Oncology, PLLC, Hermitage

37090

Tennessee Oncology, PLLC, Lebanon

37129

Tennessee Oncology, PLLC, Murfreesboro

37160

Tennessee Oncology, PLLC, Shelbyville

37167

Tennessee Oncology, PLLC, Smyrna

37203

Tennessee Oncology, PLLC, Nashville

The Sarah Cannon Research Institute, Nashville

37205

Tennessee Oncology, PLLC, Nashville

37207

Tennessee Oncology, PLLC, Nashville

37211

Tennessee Oncology, PLLC, Nashville

45211

Oncology Hematology Care, Inc., Cincinnati

45230

Oncology Hematology Care Inc, Cincinnati

45236

Oncology Hematology Care Inc, Cincinnati

45242

Oncology Hematology Care, Inc., Cincinnati

75063

US Oncology Investigational Products Center (IPC), Irving

US Oncology Investigational Products Center, Irving

76022

Texas Oncology Bedford, Bedford

76104

Texas Oncology, Fort Worth

78240

Texas Oncology- San Antonio, San Antonio

85016

Arizona Oncology Associates, PC - HAL, Phoenix

85027

Arizona Oncology Associates, PC - HAL, Phoenix

85258

Arizona Oncology Associates, PC - HAL, Scottsdale

85284

Arizona Oncology Associates, PC - HAL, Tempe

85704

Arizona Oncology Associates, PC - HOPE, Tucson

85711

Arizona Oncology Associates, PC - HOPE, Tucson

93105

Sansum Clinic, Santa Barbara

93463

Sansum Clinic, Solvang

97062

Northwest Cancer Specialists, P.C., Tualatin

97225

Northwest Cancer Specialists, P.C., Portland

97227

Northwest Cancer Specialists, P.C., Portland

98684

Northwest Cancer Specialists, P.C., Vancouver

121309

"Limited Liability Company VitaMed (LLC VitaMed)", Moscow

169608

Department of Nuclear Medicine and Molecular Imaging, Singapore

SingHealth Investigational Medicine Unit, Singapore

169610

National Cancer Centre Singapore, Singapore

169856

Department of Pathology, Singapore

188770

Raffles Hospital, Singapore

Raffles Radiology, Singapore

217562

Farrer Park Hospital, Singapore

06510

Smilow Cancer Hospital at Yale-New Haven, New Haven

97213-2982

Northwest Cancer Specialists, P.C., Portland

T12 DV56

Bon Secours Hospital, Cork

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

951-8566

Niigata Cancer Center Hospital, Niigata

02841

Korea University Anam Hospital, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

06229

Gangnam Severance Hospital, Seoul

06273

Gangnam Severance Hospital, Seoul

06351

Clinical Trial Pharmacy, Samsung Medical Center, Seoul

Samsung Medical Center, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03642132 - Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) | Biotech Hunter | Biotech Hunter